Like other ICs, LAG3 likely evolved as an immuno-regulatory strategy to protect from organ damage during aberrant or excessive immune activation (e.g., allergy, autoimmunity, inflammatory bowel disease)[1–4]; however, when a strong immune response is desired, misplaced LAG3-mediated immunosuppression may be detrimental. The gene discussed is LAG3; the disease is inflammatory bowel disease.